Fluidigm, which makes high-throughput sequencing devices and consumables for genetic labs, raised $75 million by offering 5.6 million shares at $13.50, at the low end of the range of $13.50 to $15.50. The company had originally expected to sell 5.2 million shares. Fluidigm plans to list on the NASDAQ under the symbol FLDM. Deutsche Bank Securities and Piper Jaffray acted as lead managers on the deal.